| Responsiveness of cardiometabolic-related microbiota to diet is influenced by host genetics A O’Connor, PM Quizon, JE Albright, FT Lin, BJ Bennett Mammalian Genome 25 (11), 583-599, 2014 | 79 | 2014 |
| Equipotent inhibition of fatty acid amide hydrolase and monoacylglycerol lipase–dual targets of the endocannabinoid system to protect against seizure pathology V Naidoo, DA Karanian, SK Vadivel, JR Locklear, JAT Wood, M Nasr, ... Neurotherapeutics 9 (4), 801-813, 2012 | 62 | 2012 |
| Molecular mechanism: ERK signaling, drug addiction, and behavioral effects WL Sun, PM Quizon, J Zhu Progress in molecular biology and translational science 137, 1-40, 2016 | 59 | 2016 |
| High-Resolution Genetic Mapping in the Diversity Outbred Mouse Population Identifies Apobec1 as a Candidate Gene for Atherosclerosis TL Smallwood, DM Gatti, P Quizon, GM Weinstock, KC Jung, L Zhao, ... G3: Genes, Genomes, Genetics 4 (12), 2353-2363, 2014 | 55 | 2014 |
| Molecular mechanism of HIV-1 Tat interacting with human dopamine transporter Y Yuan, X Huang, NM Midde, PM Quizon, WL Sun, J Zhu, CG Zhan ACS chemical neuroscience 6 (4), 658-665, 2015 | 51 | 2015 |
| Mutations at tyrosine 88, lysine 92 and tyrosine 470 of human dopamine transporter result in an attenuation of HIV-1 Tat-induced inhibition of dopamine transport NM Midde, Y Yuan, PM Quizon, WL Sun, X Huang, CG Zhan, J Zhu Journal of Neuroimmune Pharmacology 10, 122-135, 2015 | 31 | 2015 |
| HIV-1 transgenic rats display an increase in [3H]dopamine uptake in the prefrontal cortex and striatum J Zhu, Y Yuan, NM Midde, AM Gomez, WL Sun, PM Quizon, CG Zhan Journal of neurovirology 22, 282-292, 2016 | 21 | 2016 |
| Molecular mechanism: the human dopamine transporter histidine 547 regulates basal and HIV-1 Tat protein-inhibited dopamine transport PM Quizon, WL Sun, Y Yuan, NM Midde, CG Zhan, J Zhu Scientific reports 6 (1), 39048, 2016 | 19 | 2016 |
| Automated multi‐attribute method sample preparation using high‐throughput buffer exchange tips Y Ogata, PM Quizon, NS Nightlinger, P Sitasuwan, C Snodgrass, LA Lee, ... Rapid Communications in Mass Spectrometry 36 (3), e9222, 2022 | 16 | 2022 |
| Role of histidine 547 of human dopamine transporter in molecular interaction with HIV-1 Tat and dopamine uptake Y Yuan, PM Quizon, WL Sun, J Yao, J Zhu, CG Zhan Scientific reports 6 (1), 27314, 2016 | 16 | 2016 |
| Allosteric modulatory effects of SRI-20041 and SRI-30827 on cocaine and HIV-1 Tat protein binding to human dopamine transporter WL Sun, PM Quizon, Y Yuan, W Zhang, S Ananthan, CG Zhan, J Zhu Scientific reports 7 (1), 3694, 2017 | 15 | 2017 |
| Genetic network identifies novel pathways contributing to atherosclerosis susceptibility in the innominate artery J Albright, PM Quizon, AJ Lusis, BJ Bennett BMC Medical Genomics 7, 1-15, 2014 | 11 | 2014 |
| SRI-32743, a novel allosteric modulator, attenuates HIV-1 Tat protein-induced inhibition of the dopamine transporter and alleviates the potentiation of cocaine reward in HIV-1 … J Zhu, PM Quizon, Y Wang, CA Adeniran, MJ Strauss, AC Jiménez-Torres, ... Neuropharmacology 220, 109239, 2022 | 9 | 2022 |
| Mutational effects of human dopamine transporter at tyrosine88, lysine92, and histidine547 on basal and HIV-1 Tat-inhibited dopamine transport WL Sun, PM Quizon, Y Yuan, MJ Strauss, R McCain Jr, CG Zhan, J Zhu Scientific reports 9 (1), 3843, 2019 | 9 | 2019 |
| Mutations of Human DopamineTransporter at Tyrosine88, Aspartic Acid206, and Histidine547 Influence Basal and HIV-1 Tat‐inhibited Dopamine Transport PM Quizon, Y Yuan, Y Zhu, Y Zhou, MJ Strauss, WL Sun, CG Zhan, J Zhu Journal of Neuroimmune Pharmacology, 1-16, 2021 | 5 | 2021 |
| Mutations of tyrosine 467 in the human norepinephrine transporter attenuate HIV-1 Tat-induced inhibition of dopamine transport while retaining physiological function MJ Strauss, KD Porter, PM Quizon, SE Davis, S Lin, Y Yuan, ... Plos one 17 (9), e0275182, 2022 | 3 | 2022 |
| Diet and genetic‐induced differences in the intestinal microbiome relate to cardiometabolic phenotype (637.13) A O'Connor, F Lin, P Quizon, A Nestor, J Albright, B Bennett The FASEB Journal 28, 637.13, 2014 | 1 | 2014 |
| Mutations on human norepinephrine transporter at tyrosine 467 and human dopamine transporter at tyrosine 470 are critical for HIV-1 Tat-induced inhibition of dopamine transport PM Quizon, MJ Strauss, Y Yuan, S Lin, CG Zhan, J Zhu JOURNAL OF NEUROIMMUNE PHARMACOLOGY 14 (2), 361-361, 2019 | | 2019 |
| Effects of Human Dopamine Transporter (DAT) Mutations and Novel Allosteric Modulatory Compounds in Disrupting HIV-1 Tat-DAT Protein Interaction PMP Quizon University of South Carolina, 2019 | | 2019 |
| Inducible HIV-1 Tat transgenic mice display a decrease in [3H] Dopamine uptake via the dopamine and norepinephrine transporters in the prefrontal cortex M Strauss, B O'Donovan, L Zhou, WL Sun, P Quizon, M Bardo, P Ortinski, ... JOURNAL OF NEUROIMMUNE PHARMACOLOGY 13, S82-S83, 2018 | | 2018 |
Wei-Lun Sun, PhDUniversity of North GeorgiaVerified email at sccp.sc.edu
